Fickenscher appointed AMIA president, CEO

The American Medical Informatics Association (AMIA) has appointed Kevin Fickenscher, MD, as president and CEO. Fickenscher will replace Ted Shortliffe, MD, PhD, who announced his decision to step down from the position several months ago.

Fickenscher will join AMIA on March 19 and officially start in the role on April 1.

"With the investments that have been made in IT and exchange over the last several years and the scientific advances that are being made about the best ways to manage health-related data, the field of informatics can transform healthcare practice and bioscience," he said.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.